journal
https://read.qxmd.com/read/38524902/factors-influencing-the-outcome-of-patients-with-primary-ewing-sarcoma-of-the-sacrum
#1
JOURNAL ARTICLE
Victor Rechl, Andreas Ranft, Vivek Bhadri, Benedicte Brichard, Stephane Collaud, Sona Cyprova, Hans Eich, Torben Ek, Hans Gelderblom, Jendrik Hardes, Lianne M Haveman, Wolfgang Hartmann, Peter Hauser, Philip Heesen, Heribert Jürgens, Jukka Kanerva, Thomas Kühne, Anna Raciborska, Jelena Rascon, Arne Streitbürger, Yasmin Uhlenbruch, Beate Timmermann, Josephine Kersting, Minh Thanh Pham, Uta Dirksen
BACKGROUND: Ewing sarcoma (EwS) is a rare and highly malignant bone tumor primarily affecting children, adolescents, and young adults. The pelvis, trunk, and lower extremities are the most common sites, while EwS of the sacrum as a primary site is very rare, and only few studies focusing on this location are published. Due to the anatomical condition, local treatment is challenging in sacral malignancies. We analyzed factors that might influence the outcome of patients suffering from sacral EwS...
2024: Sarcoma
https://read.qxmd.com/read/38476458/exploring-the-diagnostic-dilemma-of-indeterminate-pulmonary-nodules-in-patients-with-primary-sarcoma-of-bone
#2
JOURNAL ARTICLE
Babe Westlake, Jeffrey Brown, Jacqueline Hart, Cameron Skiby, Kevin Jones, John Groundland
INTRODUCTION: Bone sarcomas are known to have a predilection for pulmonary metastasis. Surveillance protocols are thus focused on periodic chest imaging, typically with CT scan. Pulmonary nodules can be easily identified with this modality, but smaller nodules are not readily biopsied and may not represent metastatic disease. These are called indeterminate. The natural history of indeterminate nodules in a bone sarcoma population and factors associated with progression to true metastatic disease are not clearly defined...
2024: Sarcoma
https://read.qxmd.com/read/38410124/progressive-improvement-in-5-year-survival-rates-for-extremity-soft-tissue-sarcomas-from-1999-to-2019
#3
JOURNAL ARTICLE
Ryley K Zastrow, Mohyeddine El Sayed, Christa L LiBrizzi, Andrew J Jacobs, Adam S Levin
BACKGROUND: Extremity soft-tissue sarcoma (ESTS) is a group of rare, heterogeneous malignancies. Previous studies have demonstrated a progressive improvement in 5-year survival rate over time, but recent trends are unknown. Therefore, this study aimed to provide an update on the clinical characteristics and 5-year survival rate of ESTS from 1999 to 2019. METHODS: This retrospective cohort study used the Surveillance, Epidemiology, and End Results (SEER) database...
2024: Sarcoma
https://read.qxmd.com/read/38274845/meningeal-solitary-fibrous-tumor-a-single-center-retrospective-cohort-study
#4
JOURNAL ARTICLE
Siyer Roohani, Yasemin Alberti, Maximilian Mirwald, Felix Ehret, Carmen Stromberger, Soleiman Fabris Roohani, Katja Bender, Anne Flörcken, Sven Märdian, Daniel Zips, David Kaul
BACKGROUND: Meningeal solitary fibrous tumors (SFTs) are rare, malignant, mesenchymal tumors of the central nervous system. While surgical gross total resection is widely accepted as a positive prognostic factor for local control (LC), the role of postoperative radiotherapy (PORT) remains controversial. We sought to report our institutional experience with a particular focus on outcomes after PORT. MATERIALS AND METHODS: In this single-center, retrospective cohort study, 20 patients with the primary diagnosis of histopathologically confirmed meningeal SFT were analyzed...
2024: Sarcoma
https://read.qxmd.com/read/37457440/genomic-breakpoint-characterization-and-transcriptome-analysis-of-metastatic-recurrent-desmoplastic-small-round-cell-tumor
#5
JOURNAL ARTICLE
Justin W Magrath, Dane A Flinchum, Alifiani B Hartono, Ilon N Goldberg, Madelyn Espinosa-Cotton, Krzysztof Moroz, Nai-Kong V Cheung, Sean B Lee
Desmoplastic small round cell tumor (DSRCT) is a rare pediatric cancer caused by the EWSR1-WT1 fusion oncogene. Despite initial response to chemotherapy, DSRCT has a recurrence rate of over 80% leading to poor patient prognosis with a 5-year survival rate of only 15-25%. Owing to the rarity of DSRCT, sample scarcity is a barrier in understanding DSRCT biology and developing effective therapies. Utilizing a novel pair of primary and recurrent DSRCTs, we present the first map of DSRCT genomic breakpoints and the first comparison of gene expression alterations between primary and recurrent DSRCT...
2023: Sarcoma
https://read.qxmd.com/read/37333052/fibroblast-activation-protein-expression-in-sarcomas
#6
JOURNAL ARTICLE
Jacquelyn N Crane, Danielle S Graham, Christine E Mona, Scott D Nelson, Alireza Samiei, David W Dawson, Sarah M Dry, Marwan G Masri, Joseph G Crompton, Matthias R Benz, Johannes Czernin, Fritz C Eilber, Thomas G Graeber, Jeremie Calais, Noah C Federman
OBJECTIVES: Fibroblast activation protein alpha (FAP) is highly expressed by cancer-associated fibroblasts in multiple epithelial cancers. The aim of this study was to characterize FAP expression in sarcomas to explore its potential utility as a diagnostic and therapeutic target and prognostic biomarker in sarcomas. METHODS: Available tissue samples from patients with bone or soft tissue tumors were identified at the University of California, Los Angeles. FAP expression was evaluated via immunohistochemistry (IHC) in tumor samples ( n  = 63), adjacent normal tissues ( n  = 30), and positive controls ( n  = 2) using semiquantitative systems for intensity (0 = negative; 1 = weak; 2 = moderate; and 3 = strong) and density (none, <25%, 25-75%; >75%) in stromal and tumor/nonstromal cells and using a qualitative overall score (not detected, low, medium, and high)...
2023: Sarcoma
https://read.qxmd.com/read/37261268/accuracy-of-time-to-treatment-initiation-data-in-musculoskeletal-soft-tissue-sarcoma
#7
JOURNAL ARTICLE
Joshua M Lawrenz, Jose F Vega, Jaiben George, Gannon L Curtis, Jaymeson Gordon, Amanda Maggiotto, Katherine Tullio, Dale R Shepard, John D Reith, Herbert S Schwartz, Lukas M Nystrom, Nathan W Mesko
BACKGROUND: Time to treatment initiation (TTI) is a quality metric in cancer care. The purpose of this study is to determine the accuracy of TTI data from a single cancer center registry that reports to the National Cancer Database (NCDB) for sarcoma diagnoses. METHODS: A retrospective analysis of a single Commission on Cancer (CoC)-accredited cancer center's tumor registry between 2006 and 2016 identified 402 patients who underwent treatment of a musculoskeletal soft tissue sarcoma and had TTI data available...
2023: Sarcoma
https://read.qxmd.com/read/36937506/postoperative-complication-and-reoperation-rates-following-resection-of-soft-tissue-vs-bone-malignancies-based-on-anatomic-location-in-the-inpatient-setting
#8
JOURNAL ARTICLE
Alexander M Ballatori, Shane Shahrestani, Andy Ton, Xiao T Chen, Tarek Yamout, Brandon S Gettleman, Nathanael D Heckmann, Lawrence R Menendez, Alexander B Christ
INTRODUCTION: Surgical excisions of upper and lower extremity malignancies are increasing annually, due in part to the rising incidence of sarcomas. The purpose of this study is to compare readmissions, reoperation rate, and complications following surgical excision of soft/connective tissue vs bone malignancies of the upper and lower extremities. METHODS: The Nationwide Readmissions Database (NRD) was queried from 2016-2017 to conduct a retrospective analysis of 16,435 patients diagnosed with malignant neoplasms of the long bone (ULLB, n  = 1,433) and soft tissue (ULST, n  = 2,049) of the upper limb and malignant neoplasms of the long bone (LLLB, n  = 5,422) and soft tissue (LLST, n  = 7,531) of the lower limb...
2023: Sarcoma
https://read.qxmd.com/read/36600805/soft-tissue-sarcomas-in-adults-in-ecuador-in-the-period-2010-2020
#9
JOURNAL ARTICLE
Xavier Sánchez, Andrés Moreno Roca, Ruth Jimbo-Sotomayor, Luciana Armijos Acurio, Alfredo Viloria Cestari
BACKGROUND: Soft-tissue sarcomas (STSs) are rare tumors; they represent 1% of all tumors in adults. There are new diagnostic techniques to differentiate tumor types, and surgery continues to be the most important treatment for STS. METHODS: This cross-sectional study analyzed the morbidity and mortality caused by STS in adults between 2010 and 2020 using national databases. RESULTS: A total of 8,393 patients hospitalized due to STS were reported...
2022: Sarcoma
https://read.qxmd.com/read/36573098/clinical-outcomes-of-soft-tissue-sarcoma-around-the-elbow-joint-a-retrospective-single-institution-study
#10
JOURNAL ARTICLE
Edelyn S Azurin, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Kaoru Tada, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi, Hirotaka Yonezawa, Sei Morinaga, Yohei Asano, Shiro Saito, Hiroyuki Tsuchiya
BACKGROUND: We report a retrospective case series analysis of clinical outcomes of patients with soft tissue sarcoma around the elbow. METHODS: Twenty-two patients underwent surgical tumor excision between January 1999 and May 2017, with a mean follow-up of 85.2 months. RESULTS: Six tumors were localized in the upper arm, nine in the elbow, and seven in the forearm. Sixteen tumors were deep-seated, and six were superficially located. Fifteen patients underwent wide excision, including one amputation, and 18 achieved (81...
2022: Sarcoma
https://read.qxmd.com/read/36536691/analysis-of-negative-reviews-of-orthopedic-oncology-surgeons-an-investigation-of-reviews-from-healthgrades-vitals-and-google
#11
JOURNAL ARTICLE
Leeann Qubain, Evan H Richman, Vincent Eaton, Joseph C Brinkman, Krista M Goulding
BACKGROUND: Physician review websites (PRWs) are increasing in usage and popularity. Our purpose is to characterize one-star reviews of orthopedic oncology surgeons to understand factors in healthcare that contribute to patient satisfaction. METHODS: Orthopedic oncology surgeons were randomly selected from the Musculoskeletal Tumor Society. A search for one-star reviews was performed on Google Reviews, Healthgrades, and Vitals.com. Reviews were classified as clinical or nonclinical...
2022: Sarcoma
https://read.qxmd.com/read/36353598/patient-specific-instruments-for-forearm-sarcoma-resection-and-allograft-reconstruction-in-children-results-in-4-cases
#12
JOURNAL ARTICLE
Amaury Paulmier, Mathieu Raad, Charles-Edouard Verhelle, Laurent Paul, Pierre-Louis Docquier
For pediatric malignant bone tumors located in the limbs, limb salvage surgery is the gold standard, but it requires adequate resection margins to avoid local recurrence. Primitive bone sarcomas of the forearm (radius or ulna) are very rare and the reconstruction remains challenging. We describe a method to ensure minimal but adequate resection bone margins with precision in four consecutive patients with primitive bone sarcomas of the forearm. During the preoperative planning, magnetic resonance imaging (MRI) was used to delineate the tumor and the tumor volume was transferred to computerized tomography (CT) by image fusion...
2022: Sarcoma
https://read.qxmd.com/read/36311815/risk-of-malignant-transformation-of-giant-cell-tumors-of-bone-is-8-times-lower-with-megavoltage-vs-orthovoltage-radiation-therapy
#13
REVIEW
Farah N Musharbash, Alexander Edelstein, Jad M El Abiad, Adam S Levin, Sara R Alcorn, Carol D Morris
BACKGROUND: The first-line treatment for most giant cell tumors (GCTs) of bone is surgical; radiotherapy (RT) is reserved for inoperable or refractory cases. While RT techniques have undergone a dramatic change over the past few decades, with the higher energy megavoltage RT replacing orthovoltage RT, concerns for high rates of malignant transformation following RT have limited its use. Evidence suggests a lower incidence of secondary malignancy after treatment with megavoltage compared with orthovoltage RT, but this has not been studied in GCTs...
2022: Sarcoma
https://read.qxmd.com/read/36046749/adjuvant-radiation-after-primary-resection-of-atypical-lipomatous-tumors-of-the-extremity-reduces-local-recurrence-but-increases-complications-a-multicenter-evaluation
#14
JOURNAL ARTICLE
Joshua M Lawrenz, Samuel R Johnson, Kevin Zhu, Mallory McKeon, Cullen P Moran, Jose Vega, Katherine S Hajdu, James P Norris, Leo Y Luo, Eric T Shinohara, Justin M M Cates, Brian P Rubin, John D Reith, Jennifer L Halpern, Nathan W Mesko, Herbert S Schwartz, Lukas M Nystrom, Ginger E Holt
BACKGROUND: Radiation after resection of an atypical lipomatous tumor (ALT) is controversial. This study evaluates local control and complications after the first resection of ALTs of the extremity with or without adjuvant radiation. METHODS: A dual institution, retrospective review of patients treated from 1995 to 2020 with first-time resection of an ALT in the extremity was performed. In total, 102 patients underwent adjuvant radiation (XRT group) and 68 patients were treated with surgery alone (no-XRT group)...
2022: Sarcoma
https://read.qxmd.com/read/35814640/malignant-transformation-of-giant-cell-tumor-of-bone-and-the-association-with-denosumab-treatment-a-radiology-and-pathology-perspective
#15
JOURNAL ARTICLE
K van Langevelde, A H G Cleven, A Navas Cañete, L van der Heijden, M A J van de Sande, H Gelderblom, J V M G Bovée
OBJECTIVE: Malignancy in giant cell tumor of bone (mGCTB) is categorized as primary (concomitantly with conventional GCTB) or secondary (after radiotherapy or other treatment). Denosumab therapy has been suggested to play a role in the etiology of secondary mGCTB. In this case series from a tertiary referral sarcoma center, we aimed to find distinctive features for malignant transformation in GCTB on different imaging modalities. Furthermore, we assessed the duration of denosumab treatment and lag time to the development of malignancy...
2022: Sarcoma
https://read.qxmd.com/read/35692235/oncological-and-functional-outcomes-after-hemicortical-resection-and-biological-reconstruction-using-allograft-for-parosteal-osteosarcoma-of-the-distal-femur
#16
JOURNAL ARTICLE
Olga D Savvidou, Stavros Goumenos, Ioannis Trikoupis, Angelos Kaspiris, Dimitra Melissaridou, Panagiotis Gavriil, Jimmy Georgoulis, Panayiotis J Papagelopoulos
BACKGROUND: Parosteal osteosarcoma (PAOS) is a surface osteosarcoma. Treatment options include wide excision and endoprosthetic or allograft. However, due to the low local recurrence and metastasis rate, when it appears in the posterior surface of the distal femur, the lesion can be managed with hemicortical wide resection and biological reconstruction with hemicortical allograft. The purpose of this study is to evaluate the oncological and functional outcomes of patients with parosteal osteosarcoma (PAOS) of the posterior cortex of the distal femur who underwent biological reconstruction after hemicortical resection...
2022: Sarcoma
https://read.qxmd.com/read/35655525/targeting-the-fak-src-complex-in-desmoplastic-small-round-cell-tumors-ewing-sarcoma-and-rhabdomyosarcoma
#17
JOURNAL ARTICLE
Anke E M van Erp, Melissa H S Hillebrandt-Roeffen, Niek F H N van Bree, Tim A Plüm, Uta E Flucke, Ingrid M E Desar, Emmy D G Fleuren, Winette T A van der Graaf, Yvonne M H Versleijen-Jonkers
Desmoplastic small round cell tumors (DSRCTs), Ewing sarcoma (ES), and alveolar and embryonal rhabdomyosarcoma (ARMS and ERMS) are malignant sarcomas typically occurring at young age, with a poor prognosis in the metastatic setting. New treatment options are necessary. Src family kinase inhibitor dasatinib single-agent treatment has been investigated in a phase 2 study in patients with advanced sarcomas including ES and RMS but failed as a single agent in these subtypes. Since previous studies demonstrated high FAK and Src activities in RMS and ES tissue and cell lines, and dasatinib treatment was shown to upregulate activated FAK, we hypothesized that FAK-Src combination treatment could potentially be an interesting treatment option for these tumor types...
2022: Sarcoma
https://read.qxmd.com/read/35586727/free-vascularized-fibula-salvage-of-failed-cph-in-pediatric-sarcoma-patients
#18
JOURNAL ARTICLE
Giovanna Pires, Whitney D Moss, Jessica Luo, Ruyan Zhang, Kevin B Jones, Alvin C Kwok, Jayant P Agarwal
BACKGROUND: Due to extended life expectancy and recent improvements in surgical techniques, limb salvage has replaced amputation as the gold standard and is now performed in 90-95% of upper extremity malignancies. However, many of these salvage procedures are associated with significant postsurgical complications. In particular, the clavicula pro humero (CPH) procedure is associated with high rates of nonunion. We present our experience with upper extremity salvage using the free vascularized fibular flap (VFF) after failure or nonunion of the original CPH procedure in the pediatric population...
2022: Sarcoma
https://read.qxmd.com/read/35570847/bone-metastases-in-patients-with-leiomyosarcoma-a-retrospective-analysis-of-survival-and-surgical-management
#19
JOURNAL ARTICLE
Christa L LiBrizzi, Ashish Vankara, Christian F Meyer, Adam S Levin, Carol D Morris
BACKGROUND: Leiomyosarcomas (LMS) are malignancies with smooth muscle differentiation. Metastasis to the bone is not uncommon. The literature on the clinical course and management of such metastases is limited. Our study describes the clinical course of LMS to the bone, including survival rates, prognostic factors, and surgical management. METHODS: We retrospectively reviewed 396 LMS patients presenting at an academic center between 1995 and 2020. We included LMS patients diagnosed with bone metastases and excluded patients with primary LMS of bone...
2022: Sarcoma
https://read.qxmd.com/read/35570846/plexin-b2-and-semaphorins-do-not-drive-rhabdomyosarcoma-proliferation-or-migration
#20
JOURNAL ARTICLE
Anju Karki, Reshma Purohit, Sofia Nosack, Narendra Bharathy, Joel E Michalek, Sonja Chen, Charles Keller
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma for which subsets of patients have longstanding unmet clinical needs. For example, children with alveolar rhabdomyosarcoma and metastases at diagnosis will experience only 8% disease-free 5-year survival for nonlocalized unresectable recurrent disease. Hence, development of novel therapeutic strategies is urgently needed to improve outcomes. The Plexin-Semaphorin pathway is largely unexplored for sarcoma research. However, emerging interest in the Plexin-Semaphorin signaling axis in pediatric sarcomas has led to phase I cooperative group dose-finding clinical trials, now completed (NCT03320330)...
2022: Sarcoma
journal
journal
32777
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.